Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eptacog alfa (NovoSeven) to prevent rebleeding after surgery for spontaneous supratentorial intracerebral hemorrhage
2005-003083-36Phase 2Completed
- Sponsor
- IRCCS San Matteo Foundation
- Start
- Jan 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of coagulation factor VIIa in intracerebral hemorrhage (ICH) (2 arms), sponsored by IRCCS San Matteo Foundation. Started Jan 2007; status: completed.
02
Drugs
coagulation factor VIIa
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on 2005-003083-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003083-36.